Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human mesenchymal stromal cells БМКП-7.111973
- Development stage
- Unknown
- Lead developer
- Republican Research and Practical Center of Transfusion and Medical Biotechnologies
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Human mesenchymal stromal cells БМКП-7.111973 is an approved biomedical cell product (BMKP) developed by the Republican Research and Practical Center of Transfusion and Medical Biotechnologies in Belarus. It consists of multipotent mesenchymal stromal cells (MSCs) derived from human tissue, which exert therapeutic effects primarily through paracrine signaling. These cells secrete a wide array of immunomodulatory cytokines and regenerative growth factors that help suppress excessive immune responses and facilitate tissue repair. The product is registered for clinical use in Belarus, typically targeting conditions such as graft-versus-host disease (GvHD) and various autoimmune or inflammatory disorders, although specific documented indications in public English-language sources are limited.
- Other names
- human mesenchymal stromal cellsmesenchymal stromal cells (BMKP-7.111973)
Beyond the preview
Go deeper on human mesenchymal stromal cells БМКП-7.111973.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human mesenchymal stromal cells БМКП-7.111973.